Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,641
Closed -$13K 1925
2022
Q2
$13K Buy
1,641
+121
+8% +$1.03K ﹤0.01% 1636
2022
Q1
$12K Buy
1,520
+1,414
+1,334% +$12.2K ﹤0.01% 1578
2021
Q4
$1K Sell
106
-1,069
-91% -$12.8K ﹤0.01% 1794
2021
Q3
$19K Buy
+1,175
New +$21.1K ﹤0.01% 1712
2021
Q2
Sell
-279
Closed -$6K 1913
2021
Q1
$6K Buy
+279
New +$5.51K ﹤0.01% 1631
2020
Q4
Sell
-890
Closed -$10K 1717
2020
Q3
$10K Buy
+890
New +$10.3K ﹤0.01% 988
2019
Q4
Sell
-234
Closed -$3K 1151
2019
Q3
$3K Buy
234
+134
+134% +$2.21K ﹤0.01% 839
2019
Q2
$2K Buy
100
+18
+22% +$385 ﹤0.01% 983
2019
Q1
$2K Buy
+82
New +$1.5K ﹤0.01% 880

Other funds holding AXGN

Point72 Hong Kong's AXGN Position: Q3 2022 in Review

Point72 Hong Kong sold out of Axogen (AXGN) in Q3 2022, closing a stake of 1,641 shares — an estimated $13K sold.

Point72 Hong Kong first reported a position in AXGN in Q1 2019 and held it in 9 quarters. The position peaked at $19K in Q3 2021. 126 funds tracked by Wall St. Rank hold AXGN as of Q3 2022.

  • Point72 Hong Kong reported no remaining Axogen position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,641 Axogen shares in Q3 2022, an estimated $13K.
  • Point72 Hong Kong first reported a position in Axogen in Q1 2019 and held it in 9 quarters.
  • Point72 Hong Kong's Axogen position peaked at $19K in Q3 2021.
  • 126 funds tracked by Wall St. Rank held Axogen as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.